| Literature DB >> 28875515 |
Yeon Ju Kim1, Seung Gu Park1, Beomyong Shin1,2, Jangho Kim3, Seung Won Kim4, Oak-Sung Choo1,5, Xiang Yun Yin6, Byoung Hyun Min6, Yun-Hoon Choung1,2,5.
Abstract
Mastoidectomy, the removal of infected mastoid bones, is a common surgical procedure for the treatment of chronic otitis media. Persistent and recurrent otorrhea and accumulation of keratin debris following open cavity mastoidectomy are still bothersome issues for both patients and otologists. In this study, we used human ear adipose-derived stromal cells (hEASCs) in combination with polycaprolactone (PCL) scaffolds and osteogenic differentiation medium (ODM) to regenerate temporal bone defects. The hEASCs showed stem cell phenotypes, and these characteristics were maintained up to passage 5. Mastoid bulla and cranial bone defects were induced in Sprague-Dawley rats using AgNO3 and burr hole drilling, respectively, and the rats were then divided into five groups: (1) control, (2) hEASCs, (3) hEASCs + ODM, (4) hEASCs + PCL scaffolds, and (5) hEASCs + PCL scaffolds + ODM. Osteogenesis was evaluated by micro-computed tomography and histology. Compared with the control group, the groups transplanted with hEASCs and PCL scaffolds had significantly higher bone formation along the periphery of the mastoid bulla area. Moreover, ODM synergistically enhanced bone formation in mastoid bulla defects. Our results suggest that combining hEASCs with PCL scaffolds represents a promising method for anatomical and functional reconstruction of postoperative temporal bone defects following mastoidectomy.Entities:
Keywords: human ear adipose-derived stromal cell; mastoidectomy; osteogenic differentiation; polycaprolactone; temporal bone defect
Mesh:
Substances:
Year: 2017 PMID: 28875515 DOI: 10.1002/jbm.a.36194
Source DB: PubMed Journal: J Biomed Mater Res A ISSN: 1549-3296 Impact factor: 4.396